Morningstar

Flipping the script: Scripta Therapeutics raises $12M to find disease-modifying drugs that alter transcription factor activity

$12 million seed funding round led by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR Capital, and Parkwalk Advisors, and support from Oxford University Innovation Scripta ...
Business Wire

Flipping the script: Scripta Therapeutics raises $12M to find disease-modifying drugs that alter transcription factor activity

Scripta’s unique approach is based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of the ...